The UK has approved its first-ever needle-free adrenaline treatment for severe allergic reactions, marking a major development in how anaphylaxis could be managed in emergencies.
Prof. Andrew Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President of the International Diabetes Federation, highlights why COVID-19 is a particular concern for people living with diabetes.
Dr Lucy Mackillop, Chief Medical Officer at Sensyne Health, discusses how remote monitoring can support pregnant women during and after the COVID-19 pandemic.
COVID-19 has provided an all-too-real use case for video consultations in the NHS, but it’s the power it gives patients over their own care, that will ensure it survives long after the pandemic, says Rowan Pritchard Jones.
Cheryl Lythgoe, Matron at Benenden Health, answers the top five most frequently asked questions about endometriosis including what symptoms you should look out for.
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
Tomoaki Kojima, CEO of Sourcenext Europe, explains how UK healthcare providers can overcome language barriers to help improve clinical outcomes for patients who don’t speak English as their first language.
e-Learning for Healthcare introduces the online programme of learning called e-Pain, and how it can directly benefit the NHS workforce, the wider NHS and its patients.
Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.
Dr Juliana Bowles, School of Computer Science, University of St Andrews, discusses how to tackle polypharmacy and multimorbidities with computational techniques.
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
